News
- Author:
- Caleb Rans
Publish date: December 9, 2019
At 5-year follow-up in the phase 3 D-CARE study, the researchers found no significant difference in bone metastasis-free survival between the denos...
News
- Author:
- Caleb Rans
Publish date: December 9, 2019
Investigators quantified institutional costs associated with radiation treatment options for spinal metastases and found single-fraction stereotact...
News
- Author:
- Caleb Rans
Publish date: December 4, 2019
The meta-analysis evaluated the diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma.
News
- Author:
- Caleb Rans
Publish date: December 3, 2019
“These findings suggest that unnecessary use of glucocorticoids should be avoided in the management of the disease where possible,” study authors ...
News
- Author:
- Caleb Rans
Publish date: November 20, 2019
An analysis of claims data for more than 1,000 patients with chronic lymphocytic leukemia shows that ibrutinib monotherapy is a less expensive upfr...
News
- Author:
- Caleb Rans
Publish date: November 19, 2019
Researchers said the findings from the phase 3 study support early treatment as the new standard of care in patients with high-risk smoldering mult...
News
- Author:
- Caleb Rans
Publish date: November 14, 2019
At time of first myocardial infarction, those with a breast cancer history were older, had fewer risk factors, and ultimately had better outcomes, ...
News
- Author:
- Caleb Rans
Publish date: November 13, 2019
Among 40 crizotinib-pretreated patients, 14 patients (35%) had an objective response on lorlatinib, with a median duration of response of 13.8 mont...
News
- Author:
- Caleb Rans
Publish date: November 5, 2019
The study suggests that caspofungin is a viable option for prophylaxis against invasive fungal disease in children and young adults with acute myel...
News
- Author:
- Caleb Rans
Publish date: November 1, 2019
Levofloxacin looks like a promising addition to therapy, but the researchers cautioned that antibiotic resistance must be considered.
News
- Author:
- Caleb Rans
Publish date: October 31, 2019
Total pathologic complete response rates were significantly higher for patients in the pertuzumab arm (39.3%) compared with the placebo arm (21.8%)...
News
- Author:
- Caleb Rans
Publish date: October 28, 2019
Patients who underwent Mohs micrographic surgery had moderately better survival, compared with those who were treated with wide margin excision.
News
- Author:
- Caleb Rans
Publish date: October 24, 2019
The study found that more than a third of older patients with multiple myeloma had poor adherence to lenalidomide.
News
- Author:
- Caleb Rans
Publish date: October 24, 2019
The findings raise the question of whether PD-1 blockade could resensitize tumors to chemotherapy.
News
- Author:
- Caleb Rans
Publish date: October 22, 2019
More study is needed to determine whether increasing exercise capacity would improve neurocognitive outcomes for childhood survivors of acute lymph...
